Total Liabilities: The total value of all possible claims against the corporation.
Mersana Therapeutics, Inc. (MRSN) had Total Liabilities of $122.22M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.01M |
|
$-7.54M |
|
-- |
|
$11.01M |
|
$18.68M |
|
$-7.67M |
|
$0.12M |
|
$-7.54M |
|
$-7.54M |
|
$-7.54M |
|
$-7.54M |
|
$-7.54M |
|
$-7.54M |
|
$-7.67M |
|
$-7.58M |
|
4.99M |
|
4.99M |
|
$-1.51 |
|
$-1.51 |
|
| Balance Sheet Financials | |
$59.99M |
|
$0.16M |
|
$2.70M |
|
$62.69M |
|
$43.27M |
|
-- |
|
$78.95M |
|
|
Total Liabilities |
$122.22M |
$-59.54M |
|
$-59.54M |
|
$-59.54M |
|
5.00M |
|
| Cash Flow Statement Financials | |
$-55.12M |
|
$27.77M |
|
$-24.01M |
|
$108.23M |
|
$56.87M |
|
$-51.36M |
|
$5.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-69.64% |
|
-69.64% |
|
-- |
|
-68.53% |
|
-68.53% |
|
$-54.35M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
-- |
|
65.53 |
|
1.37 |
|
12.67% |
|
12.67% |
|
-12.04% |
|
12.67% |
|
$-11.91 |
|
$-10.89 |
|
$-11.04 |
|